Related Experiment Video
Updated: Jul 18, 2025

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
Published on: June 16, 2019
Engineered hematopoietic and immune cells derived from human pluripotent stem cells
Yun Chang1, Sydney N Hummel1, Juhyung Jung1
1Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana; Purdue University Institute for Cancer Research, West Lafayette, Indiana.
Human pluripotent stem cells (hPSCs) offer a scalable and cost-effective alternative to human hematopoietic stem cells (HSCs) for cell therapies. Engineering hPSCs advances hematopoietic stem and progenitor cell (HSPC) differentiation for improved cancer immunotherapy and blood disease treatments.
Area of Science:
- Stem cell engineering
- Hematopoietic stem cell transplantation
- Cancer immunotherapy
Background:
- Significant advances in human hematopoietic stem cell (HSC) transplantation for blood diseases and cancers over the past decade.
- Persistent challenges in HSC quality, quantity, and cost for therapeutic applications.
Purpose of the Study:
- To review current developments in stem cell engineering for hematopoietic stem and progenitor cell (HSPC) differentiation.
- To explore the potential of human pluripotent stem cells (hPSCs) as a transformative cell source for HSC transplantation and cancer immunotherapy.
Main Methods:
- Generation of HSPCs from hPSCs.
- Genetic modification of hPSCs and hPSC-derived HSPCs for enhanced function.
- Differentiation of hPSCs into functional immune cells.
- Application of cell culture platforms for hematopoietic cell manufacturing.
Main Results:
- Key advances in generating functional HSPCs from hPSCs.
- Successful differentiation of hPSCs into various immune cell types.
- Development of cell culture platforms for scalable hematopoietic cell production.
Conclusions:
- hPSCs present a promising, cost-effective, and scalable cell source for HSC transplantation and cancer immunotherapy.
- Further research is needed to overcome challenges in translating hPSC-derived HSPCs and immune cells into clinical practice.
More Related Videos
12:03Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
Published on: October 31, 2012
08:14Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
Published on: December 3, 2015
Related Concept Videos
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Embryonic Stem Cells
Stem Cell Culture
Source And Potency Of Stem Cells